Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Abarelix> ?p ?o. }
Showing items 1 to 74 of
74
with 100 items per page.
- Abarelix abstract "Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.It was originally marketed by Praecis Pharmaceuticals as Plenaxis, and is now marketed by Speciality European Pharma in Germany after receiving a marketing authorisation in 2005.".
- Abarelix atcPrefix "L02".
- Abarelix atcSuffix "BX01".
- Abarelix casNumber "183552-38-7".
- Abarelix chEBI "337298".
- Abarelix drugbank "DB00106".
- Abarelix fdaUniiCode "W486SJ5824".
- Abarelix iupacName "acetyl-D-β-naphthylalanyl- D-4-chlorophenylalanyl-D-3-pyridylalanyl-L-seryl-L- N-methyl- tyrosyl-D-asparagyl-L-leucyl-L-N(e )-isopropyl-lysyl-L-prolyl-D-alanyl-amide".
- Abarelix pubchem "16131215".
- Abarelix thumbnail Abarelix.svg?width=300.
- Abarelix wikiPageID "1300790".
- Abarelix wikiPageRevisionID "541103990".
- Abarelix atcPrefix "L02".
- Abarelix atcSuffix "BX01".
- Abarelix c "72".
- Abarelix casNumber "183552".
- Abarelix chebi "337298".
- Abarelix chembl "1252".
- Abarelix chemspiderid "10482301".
- Abarelix cl "1".
- Abarelix drugbank "DB00106".
- Abarelix h "95".
- Abarelix hasPhotoCollection Abarelix.
- Abarelix inchi "1".
- Abarelix inchikey "AIWRTTMUVOZGPW-HSPKUQOVBF".
- Abarelix iupacName "acetyl-D-β-naphthylalanyl- D-4-chlorophenylalanyl-D-3-pyridylalanyl-L-seryl-L- N-methyl- tyrosyl-D-asparagyl-L-leucyl-L-N-isopropyl-lysyl-L-prolyl-D-alanyl-amide".
- Abarelix iupharLigand "1188".
- Abarelix kegg "D02738".
- Abarelix molecularWeight "1416.06".
- Abarelix n "14".
- Abarelix o "14".
- Abarelix pregnancyUs "X".
- Abarelix proteinBound "96".
- Abarelix pubchem "16131215".
- Abarelix routesOfAdministration Intramuscular_injection.
- Abarelix smiles "O=C[C@@H]6CCCN6C[C@H]NC[C@H]NC[C@@H]NC[C@H]NC[C@H]NC[C@@H]NC[C@@H]NC[C@@H]NCC".
- Abarelix stdinchi "1".
- Abarelix stdinchikey "AIWRTTMUVOZGPW-HSPKUQOVSA-N".
- Abarelix tradename "Plenaxis".
- Abarelix unii "W486SJ5824".
- Abarelix verifiedfields "changed".
- Abarelix verifiedrevid "477237014".
- Abarelix subject Category:GnRH_antagonists.
- Abarelix type Adversary109773245.
- Abarelix type CausalAgent100007347.
- Abarelix type GnRHAntagonists.
- Abarelix type LivingThing100004258.
- Abarelix type Object100002684.
- Abarelix type Organism100004475.
- Abarelix type Person100007846.
- Abarelix type PhysicalEntity100001930.
- Abarelix type Whole100003553.
- Abarelix type YagoLegalActor.
- Abarelix type YagoLegalActorGeo.
- Abarelix type Drug.
- Abarelix type DrugProduct.
- Abarelix type FunctionalSubstance.
- Abarelix comment "Abarelix (trade name Plenaxis) is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.It was originally marketed by Praecis Pharmaceuticals as Plenaxis, and is now marketed by Speciality European Pharma in Germany after receiving a marketing authorisation in 2005.".
- Abarelix label "Abarelix".
- Abarelix label "Abarelix".
- Abarelix label "Abarelix".
- Abarelix label "Abarelix".
- Abarelix label "أباريليكس (عقار)".
- Abarelix sameAs Abarelix.
- Abarelix sameAs Abarelix.
- Abarelix sameAs Abarelix.
- Abarelix sameAs m.04r3kr.
- Abarelix sameAs Q305555.
- Abarelix sameAs Q305555.
- Abarelix sameAs DB00106.
- Abarelix sameAs Abarelix.
- Abarelix wasDerivedFrom Abarelix?oldid=541103990.
- Abarelix depiction Abarelix.svg.
- Abarelix isPrimaryTopicOf Abarelix.